A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers.

NCT07176728 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Sepsis Associated Disseminated Intravascular Coagulation (DIC)

Interventions

DRUG: BAY 3389934
DRUG: Matching Placebo / Diluent

Sponsor

Bayer